Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Singla

Showing results (51-60 of 4,968) with videos related to

Pageof 497
Sort By:
Medical Hypotheses|October 19, 2006
Role of Tryptophan supplementation in the treatment of ChlamydiaMohit Singla
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|September 6, 2021
Novel Strategies in Locally Advanced Kidney Cancer - Highlights from KEYNOTE-564Nirmish Singla
European Urology|July 2, 2019
The Value of Protecting Research Time During TrainingNirmish Singla
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|March 7, 2022
How Can We Predict pT3a Kidney Cancer and What Does It Mean?: Commentary for the article "Radiological Correlates of pT3a Kidney Cancer: Importance of Irregular Tumor Sinus Border"Nirmish Singla
Medical Hypotheses|December 5, 2006
Antibody based target tailored antimicrobial chemotherapy - a new approachMohit Singla
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|August 9, 2020
Uveal Melanoma and Kidney Cancer: More Similar than Meets the EyeNirmish Singla
JAMA Oncology|March 6, 2020
A New Therapeutic Era for Metastatic Renal Cell Carcinoma: Call for a New Prognostic ModelNirmish Singla
European Urology|November 3, 2019
Re: Brian I. Rini, Thomas Powles, Michael B. Atkins, et al. Atezolizumab plus Bevacizumab Versus Sunitinib in Patients with Previously Untreated Metastatic Renal Cell Carcinoma (IMmotion151): A Multicentre, Open-label, Phase 3, Randomised Controlled Trial. Lancet 2019;393:2404-15: Putting IMmotion into Motion: Personalizing Frontline Treatment for Metastatic Renal Cell CarcinomaNirmish Singla
Journal of Neurosciences in Rural Practice|November 29, 2012
CommentaryN Singla
The Journal of Urology|January 26, 2023
Editorial CommentNirmish Singla
Pageof 497

Showing results (51-60 of 4,968) with videos related to

Sort By:
Pageof 497
Medical Hypotheses|October 19, 2006
Role of Tryptophan supplementation in the treatment of ChlamydiaMohit Singla
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|September 6, 2021
Novel Strategies in Locally Advanced Kidney Cancer - Highlights from KEYNOTE-564Nirmish Singla
European Urology|July 2, 2019
The Value of Protecting Research Time During TrainingNirmish Singla
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|March 7, 2022
How Can We Predict pT3a Kidney Cancer and What Does It Mean?: Commentary for the article "Radiological Correlates of pT3a Kidney Cancer: Importance of Irregular Tumor Sinus Border"Nirmish Singla
Medical Hypotheses|December 5, 2006
Antibody based target tailored antimicrobial chemotherapy - a new approachMohit Singla
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|August 9, 2020
Uveal Melanoma and Kidney Cancer: More Similar than Meets the EyeNirmish Singla
JAMA Oncology|March 6, 2020
A New Therapeutic Era for Metastatic Renal Cell Carcinoma: Call for a New Prognostic ModelNirmish Singla
European Urology|November 3, 2019
Re: Brian I. Rini, Thomas Powles, Michael B. Atkins, et al. Atezolizumab plus Bevacizumab Versus Sunitinib in Patients with Previously Untreated Metastatic Renal Cell Carcinoma (IMmotion151): A Multicentre, Open-label, Phase 3, Randomised Controlled Trial. Lancet 2019;393:2404-15: Putting IMmotion into Motion: Personalizing Frontline Treatment for Metastatic Renal Cell CarcinomaNirmish Singla
Journal of Neurosciences in Rural Practice|November 29, 2012
CommentaryN Singla
The Journal of Urology|January 26, 2023
Editorial CommentNirmish Singla
Pageof 497